A clinical guideline summary in the Annals of Internal Medicine reviewed the American Diabetes Association's updated Standards of Medical Care in Diabetes, which recommends the use of continuous glucose monitoring or self-monitoring of blood glucose at specific time points for patients with diabetes using intensive insulin treatment to reduce A1C and the use of sensor-augmented pump therapy to improve glycemic control. Patients can also substitute intermittently scanned CGM for SMBG if they need frequent glucose testing, while automated insulin delivery systems can be considered for children with type 1 diabetes, ages 7 or older.
A look at technology use in ADA's updated diabetes care standards
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.